Comparison of the Metabolic Effects of Ritonavir-Boosted Darunavir or Atazanavir Versus Raltegravir, and the Impact of Ritonavir Plasma Exposure: ACTG 5257

Background. Metabolic effects following combination antiretroviral therapy (cART) vary by regimen type. Changes in metabolic effects were assessed following cART in the AIDS Clinical Trials Group (ACTG) A5257 study, and correlated with plasma ritonavir trough concentrations (C(24)). Methods. Treatme...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Clin Infect Dis
Glavni autori: Ofotokun, Ighovwerha, Na, Lumine H., Landovitz, Raphael J., Ribaudo, Heather J., McComsey, Grace A., Godfrey, Catherine, Aweeka, Francesca, Cohn, Susan E., Sagar, Manish, Kuritzkes, Daniel R., Brown, Todd T., Patterson, Kristine B., Para, Michael F., Leavitt, Randi Y., Villasis-Keever, Angelina, Baugh, Bryan P., Lennox, Jeffrey L., Currier, Judith S.
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2015
Teme:
HIV/AIDS
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4660025/
https://ncbi.nlm.nih.gov/pubmed/25767256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ193
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items